BRIEF-Emergent Biosolutions signs $53 mln modification to Barda contract for manufacture of botulism antitoxin
March 31 Emergent Biosolutions Inc
* Emergent Biosolutions signs $53 million modification to Barda contract for the manufacture of botulism antitoxin
* Emergent Biosolutions - modification to contract will enable future filling and deliveries of final drug product to strategic national stockpile Source text for Eikon: Further company coverage:
U.S. Marine Corps to resume F-35 operations a day after suspension at Arizona base
June 23 The U.S. Marine Corps said on Friday it resumed flight operations for Lockheed Martin Corp's F-35B fighter jets after temporarily suspended operations a day ago because of software problems.
Gunman in California UPS shooting targeted co-workers for slayings
June 23 The UPS employee who shot three coworkers to death last week inside a United Parcel Service facility in San Francisco before killing himself appears to have singled out his victims deliberately, but a motive remains unknown, police said on Friday.